{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:52:35Z","timestamp":1772052755529,"version":"3.50.1"},"reference-count":6,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2024.1523215","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:51:31Z","timestamp":1734537091000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: X-linked retinoschisis: mechanisms and therapies"],"prefix":"10.3389","volume":"11","author":[{"given":"Alina V.","family":"Dumitrescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene V.","family":"Drack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 gene therapy for x-linked retinoschisis: initial findings from a phase I\/IIA trial by intravitreal delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.oret.2022.06.013","article-title":"Intravitreal Delivery of rAAV2tYF-CB-hRS1 vector for gene augmentation therapy in patients with X-linked retinoschisis: 1-year clinical results","volume":"6","author":"Pennesi","year":"2022","journal-title":"Ophthalmol Retina."},{"key":"B3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000094799","article-title":"The role of caspases in photoreceptor cell death of the retinoschisin-deficient mouse","volume":"115","author":"Gehrig","year":"2006","journal-title":"Cytogenet Genome Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.oret.2023.12.003","article-title":"Efficacy of carbonic anhydrase inhibitors on cystoid fluid collections and visual acuity in patients with X-linked retinoschisis","volume":"8","author":"Hensman","year":"2024","journal-title":"Ophthalmol Retina."},{"key":"B5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/13816810.2019.1660381","article-title":"Efficacy of topical brinzolamide in children with retinal dystrophies","volume":"40","author":"Scruggs","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/01.iae.0000237081.80600.51","article-title":"Use of dorzolamide for patients with X-linked retinoschisis","volume":"26","author":"Apushkin","year":"2006","journal-title":"Retina."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1523215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:51:33Z","timestamp":1734537093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1523215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":6,"alternative-id":["10.3389\/fmed.2024.1523215"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1523215","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"article-number":"1523215"}}